Neuralace Medical’s Axon Therapy mPNS, for the treatment of chronic painful diabetic neuropathy (PDN), is the first US Food & Drug Administration–cleared non-invasive, magnetic peripheral nerve stimulation (mPNS) treatment for PDN. The device utilizes a pioneering approach of mPNS to deliver a quick, painless, and non-invasive treatment, while enhancing quality of life for patients. Each session, lasting just 13.5 minutes, harnesses the power of magnetic pulses to provide relief, representing a significant advancement in pain management. In a recent double-blind multi-center randomized controlled trial involving 71 patients, Axon Therapy demonstrated remarkable efficacy.
Neuralace Medical
855/473-2966
